Metoprolol Tartrate Injection (1mg/mL)

Hazard statements (CLP)

H319, H361, H362

Code

Statements

H319

Causes serious eye irritation

SECTION 2: Hazards identification

1999/45/EC EMERGENCY OVERVIEW

Product definition

This product is a clear colorless solution with no odor

Health hazards

Potential health hazards include hypertension and angina, tiredness and dizziness. Long term effects may include bradycardia, hypotension, bronchospasm, and cardiac failure. Flammability Hazards: This product is non-flammable Reactivity Hazards: None known

Environmental hazards

The Environmental effects of this product have not been investigated. Release of this product is not expected to have significant adverse effects in the aquatic environment. US DOT SYMBOLS

Classification according to GHS

Reproductive Toxicity Category 2 Eye Irritant Category 2A

Hazard statements

H361 – Suspected of damaging fertility or the unborn child H362 – May cause harm to breast-fed children H319 - Causes serious eye irritation

Precautionary statements

P264: Wash skin after handling

Response

P305+P351+P338 IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing

Storage

P403+P235: Store in a well ventilated place. Keep cool

Disposal

P501: Dispose of contents/container in accordance with local/regional/national/international regulations Other Known Hazard(s): This mixture has not been tested to the criteria for PBT or vPvB in accordance with Annex VII. No other hazards known 2.3 HEALTH HAZARDS OR RISKS FROM EXPOSURE: SYMPTOMS OF OVEREXPOSURE BY ROUTE OF EXPOSURE: The most significant routes of exposure for this product are by injection, ingestion, inhalation and skin or eye contact. ACUTE: Potential health hazards include hypertension and angina, tiredness and dizziness. May cause reproductive harm. CHRONIC: Long term effects may include bradycardia, hypotension, bronchospasm, and cardiac failure. TARGET ORGANS Acute Central Nervous System Chronic: Central Nervous System, Cardiac

2.1 Classification of the substance or mixture

EUROPEAN UNION DIRECTIVES: This product does meet the definition of a hazardous substance or preparation as defined by 29 CFR 1910. 1200 AND the European Union Council Directives 67/548/EEC, 1999/45/EC, 1272/2008/EC and subsequent Directives. EU HAZARD CLASSIFICATION OF INGREDIENTS PER DIRECTIVE 1272/2008/EC: EC# 260-148-9 This substance is not classified in the Annex VI EC# 231-598-3 This substance is not classified in the Annex VI EC# 231-791-2 This substance is not classified in the Annex VI Substances not listed either individually or in group entries must be self classified. Component(s) Contributing to Classification(s) All Ingredients